Korea Research Institute of Bioscience and Biotechnology

St Pharm Co., Ltd.

Sun-Jung Cho

Young Ho Kim

Chae-Ok Yun

Young Il Yeom

Hee Gu Lee

Kyung-Sook Chung

Eun Young Song

Moon Hee Kim

Young-Joo Kim

Kyeong-Eun Jung

Misun Won

Seon-Young Kim

Kyung Bin Song

Ho Kyung Chun

Shin-Jung Choi

Provided are a composition for diagnosing cancer or screening an anticancer drug comprising an FLJ25416 gene or an antibody directed to a protein expressed from the FLJ25416 gene, a composition for treating cancer comprising an inhibitor of the gene or an inhibitor of the protein expressed from the gene and a pharmaceutically acceptable carrier, and a kit for diagnosing cancer comprising at least one of the FLJ25416 gene and the protein expressed from the FLJ25416 gene. The FLJ25416 gene is expressed at high level in specific cancer cells, and induces an increase in proliferation rate of normal cells. The expression of the gene is suppressed, which results in an inhibitory effect on cancer cell growth. Thus, the FLJ25416 gene can be used as a target gene for diagnosis or treatment of cancer.

Use of FLJ25416 gene

Growing community of inventors

Gyeongju-si, South Korea

Sun-Jung Cho